Haseeb Muhammad, Khan Zubair, Kamal Muhammad Umar, Jirapinyo Pichamol, Thompson Christopher C
Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Gastroenterology, University of Texas at Houston Health Science Center, Houston, Texas, USA.
Gastrointest Endosc. 2023 May;97(5):871-879.e2. doi: 10.1016/j.gie.2023.01.004. Epub 2023 Jan 11.
Peroral endoscopic myotomy (POEM), laparoscopic Heller myotomy (LHM), and pneumatic dilation (PD) are the most common modalities for management of achalasia. Our study aimed to directly compare their short-term outcomes and safety profile in a hospitalized cohort in the United States.
The National Readmission Database (2016-2019) was queried using International Classification of Diseases, Tenth Revision, Clinical Modification codes to identify a cohort of inpatient admissions who underwent POEM, LHM, or PD. Baseline demographic variables, resource utilization, periprocedural outcomes, and 30-day readmissions were analyzed. A univariate and multivariate logistic regression model was used to compare odds of readmission with POEM as a reference.
LHM was the most performed procedure (n = 9710) as compared with PD (n = 2453) and POEM (n = 1911). Patients undergoing PD were older with a higher Charlson Comorbidity Index. The 30-day readmission rate was 4.3%, 3.9%, and 12.6% for POEM, LHM, and PD, respectively. Compared with POEM, the adjusted odds of readmission for PD was 2.42 (95% confidence interval, 1.56-3.75). There was no statistically significant difference in odds of readmission for LHM (.91; 95% confidence interval, .62-1.33) compared with POEM. Within the 30-day readmitted population, 13.1% of PD and 3.4% of LHM patients required achalasia-related procedural intervention. The rate of bleeding (4.3%), blood transfusion (2.3%), and mortality were higher (1.1%) in PD as compared with POEM and LHM.
In the United States, the risk of readmission and resource utilization are higher in patients with achalasia undergoing PD. The outcomes are comparable between POEM and LHM, but there is a significant difference between the utilization of these myotomy procedures.
经口内镜下肌切开术(POEM)、腹腔镜Heller肌切开术(LHM)和气囊扩张术(PD)是治疗贲门失弛缓症最常用的方法。我们的研究旨在直接比较它们在美国住院患者队列中的短期疗效和安全性。
使用国际疾病分类第十版临床修订本代码查询国家再入院数据库(2016 - 2019年),以确定接受POEM、LHM或PD治疗的住院患者队列。分析基线人口统计学变量、资源利用情况、围手术期结局和30天再入院情况。采用单因素和多因素逻辑回归模型,以POEM作为参照比较再入院的几率。
与PD(n = 2453)和POEM(n = 1911)相比,LHM是实施最多的手术(n = 9710)。接受PD治疗的患者年龄较大,查尔森合并症指数较高。POEM、LHM和PD的30天再入院率分别为4.3%、3.9%和12.6%。与POEM相比,PD再入院的校正几率为2.42(95%置信区间,1.56 - 3.75)。与POEM相比,LHM再入院几率无统计学显著差异(.91;95%置信区间,.62 - 1.33)。在30天再入院人群中,13.1%的PD患者和3.4%的LHM患者需要进行与贲门失弛缓症相关的手术干预。与POEM和LHM相比,PD的出血率(4.3%)、输血率(2.3%)和死亡率(1.1%)更高。
在美国,接受PD治疗的贲门失弛缓症患者再入院风险和资源利用更高。POEM和LHM的疗效相当,但这些肌切开术的使用情况存在显著差异。